Alo Hakeem's $165K Pre-Seed Backs Syria Home Healthcare Rollout

Alo Hakeem, a Syria-based healthtech startup, has closed a $165K pre-seed round led by Ebla Ventures. The funding was announced about a year after the company's founding in 2025.

The company operates a digital platform that connects patients with home healthcare services. Among the services available through the platform are medical consultations, home nursing, physiotherapy, radiology and laboratory testing — a slate that spans routine care and diagnostics delivered outside a hospital or clinic setting.

Alo Hakeem was founded by Abdul Latif Al-Baroudi. Its platform currently operates in three Syrian cities: Damascus, Hama and Aleppo.

According to the announcement, the company intends to use the capital to strengthen its technology infrastructure and to transition from its minimum viable product to the official launch of its app in November. The funds will also support expansion of home healthcare services across Syria — a signal that the startup sees its three-city footprint as a starting point rather than an end state.

The round is small by regional standards, but pre-seed checks of this size are typical for first-time founders building in markets where healthcare infrastructure is thin and where patients often piece together providers on their own. Ebla Ventures is the sole named investor on the round.

Alo Hakeem is categorized as a healthtech company. The funding date was October 2026.

What happens after November will test whether a platform model works in a country where service delivery, logistics and payment rails are all difficult. For now, the company's stated priority is narrower: get the product out of MVP, get the app launched, and extend home healthcare services beyond the cities where it already operates.